Article

The Patient Journey and Guideline Concordant Care in Colorectal Cancer – Is Current Practice Enough?

2026-03-04

Abstract excerpt

Colorectal cancer is a major healthcare burden, and modern management of non-metastatic disease relies heavily on guideline concordant care with a basis in histopathologic staging and empiric systemic therapy. While multidisciplinary care pathways and standardized guidelines have improved outcomes at a population level, they fall short in addressing the inter-patient and intra-tumoral heterogeneity that drives lac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bedb76f7-ffc5-5b17-a087-00b31479b545
DOI: 10.20944/preprints202602.1161.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Patient Journey and Guideline Concordant Care in Colorectal Cancer – Is Current Practice Enough?DOI 10.20944/preprints202602.1161.v2Read

The Patient Journey and Guideline Concordant Care in Colorectal Cancer – Is Current Practice Enough?Semantic proximity Read

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity Read

From tumour heterogeneity to advances in precision treatment of colorectal cancerSemantic proximity Read

Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy ResponseSemantic proximity Read

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.Semantic proximity Read

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitorsSemantic proximity Read

Functional precision oncology using patient-derived assays: bridging genotype and phenotype.Semantic proximity Read

Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?Semantic proximity Read

How the lab is changing our view of colorectal cancer.Semantic proximity Read

Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachSemantic proximity Read

BRAFV600E patient derived colon cancer organoids identify biomarkers of response to EGFR and BRAF inhibition and replicate clinical data.Semantic proximity Read

The confounding effects of tumour heterogeneity and cellular plasticity on personalized surgical management of colorectal cancer.Semantic proximity Read